Effectiveness of Mp-3 Microperimetric Biofeedback Fixation Training For Low Vision Rehabilitation in Patients Treated With Corticosteroid Ivt in Retinal Vein Occlusions

References

• McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1113–1123.e15. doi:10.1016/j.ophtha.2010.01.060
   PubMed Web of Science ®Google Scholar
• Pacella F, Bongiovanni G, Malvasi M, et al. Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion. Clin Ter. 2020;171(6):e534–e538. PMID: 33151253. doi:10.7417/CT.2020.2269
   PubMed Web of Science ®Google Scholar
• Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126:513–518. doi:10.1001/archopht.126.4.513
   PubMed Web of Science ®Google Scholar
• Klein R, E. KB, Moss SE, Meueret S M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2001;98:133–141.
   Google Scholar
• Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:724780. doi:10.1155/2014/724780
   PubMed Web of Science ®Google Scholar
• Stefanutti C, Mesce D, Pacella F, et al. Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis. Atheroscler Suppl. 2019;40:49–54. doi:10.1016/j.atherosclerosissup.2019.08.031
   PubMed Web of Science ®Google Scholar
• Pacella E, Vestri AR, Muscella R, et al. Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema. Clin Ophthalmol. 2013;7:1423–1428. doi:10.2147/OPTH.S48364
   PubMedGoogle Scholar
• Pacella F, Ferraresi AF, Turchetti P, et al. Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up. Ophthalmol Eye Dis. 2016;8:11–16. doi:10.4137/OED.S38028
   PubMedGoogle Scholar
• Pacella F, Romano MR, Turchetti P, et al. An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy. Int J Ophthalmol. 2016;9:1427–1432. doi:10.18240/ijo.2016.10.10
   PubMed Web of Science ®Google Scholar
• La Torre G, Pacella E, Saulle R, et al. The synergistic effect of exposure to alcohol, tobacco smoke and other risk factors for age-related macular degeneration. Eur J Epidemiol. 2013;28(5):445–446. PMID: 23543124. doi:10.1007/s10654-013-9798-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu S, Wen F, Cao Q. Diabetes mellitus as a risk factor for retinal vein occlusion: a meta-analysis. Medicine. 2020;99:e19319. doi:10.1097/MD.0000000000019319
   PubMedGoogle Scholar
• Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9:010427. doi:10.7189/jogh.09.010427
   PubMed Web of Science ®Google Scholar
• Fehér J, Kovács I, Pacella E, et al. A mikroflóra és a bélnyálkahártya kölcsönhatása az irritábilis bél, irritábilis szem és irritábilis elme szindróma kórtanában és kezelésében (Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind syndrome). Orv Hetil. 2014;155(37):1454–1460. doi:10.1556/OH.2014.29987
   PubMedGoogle Scholar
• Glacet-Bernard A, Coscas G, Zourdani A, Soubrane G, E.h S. Steroids and macular edema from retinal vein occlusion. Eur J Ophthalmol. 2011;21(Suppl 6):S37–44. PMID: 23264327. doi:10.5301/EJO.2010.6053
   PubMedGoogle Scholar
• M. VE, Cavarretta S, Domanico D, Parisi F, Malagola R. Microperimetric biofeedback in AMD patients. Appl Psychophys Biofeed. 2007;32(3–4):185–189. doi:10.1007/s10484-007-9038-6
   PubMed Web of Science ®Google Scholar
• Pacella E, Pacella F, La Torre G, et al. Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment. Clin Ter. 2012;163(6):e413–22.
   PubMed Web of Science ®Google Scholar
• Tonti E, Budini M, Vingolo EM. Visuo-Acoustic Stimulation’s Role in Synaptic Plasticity: a Review of the Literature. Int J Mol Sci. 2021;22(19):10783. PMID: 34639122; PMCID: PMC8509608. doi:10.3390/ijms221910783
   PubMed Web of Science ®Google Scholar
• Rosengarth K, Keck I, Brandl-Rühle S, et al. Functional and structural brain modifications induced by oculomotor training in patients with age-related macular degeneration. Front Psychol. 2013;4:428. PMID: 23882237; PMCID: PMC3713239. doi:10.3389/fpsyg.2013.00428
   PubMed Web of Science ®Google Scholar
• Andrade MA, Muro EM, Morán F. Simulation of plasticity in the adult visual cortex. Biol Cybern. 2001;84(6):445–451. PMID: 11417056. doi:10.1007/PL00007988
   PubMed Web of Science ®Google Scholar
• Safran AB, Landis T. Plasticity in the adult visual cortex: implications for the diagnosis of visual field defects and visual rehabilitation. Curr Opin Ophthalmol. 1996;7(6):53–64. PMID: 10166554. doi:10.1097/00055735-199612000-00009
   PubMedGoogle Scholar
• Vingolo EM, Salvatore S, Cavarretta S. Low-vision rehabilitation by means of mp-1 biofeedback examination in patients with different macular Diseases: A Pilot Study. Appl Psychophysiol Biofeed. 2009;(34):127–133.
   PubMedGoogle Scholar
• Vingolo EM, Napolitano G, Fragiotta S. Microperimetric biofeedback training: fundamentals, strategies and perspectives. Front Biosci. 2018;10(1):48–64. PMID: 28930518. doi:10.2741/s500
   Google Scholar
• Giorgi D, Contestabile MT, Pacella E, C.b G. An instrument for biofeedback applied to vision. Appl Psychol Biofee. 2005;30(4):389–395. PMID: 16385426. doi:10.1007/s10484-005-8424-1
   PubMed Web of Science ®Google Scholar
• Sborgia G, Niro A, Tritto T, et al. Microperimetric biofeedback training after successful inverted flap technique for large macular hole. J Clin Med.;9(2):556. PMID: 32085592; PMCID: PMC7074367. doi:10.3390/jcm9020556
   PubMed Web of Science ®Google Scholar
• Pacella E, Pacella F, Mazzeo F, et al. Effectiveness of vision rehabilitation treatment through MP-1 microperimeter in patients with visual loss due to macular disease. Clin Ter. 2012;163(6):e423–8. PMID: 23306757.
   PubMed Web of Science ®Google Scholar
• Bozkurt Oflaz A, Öztürk B T, Ş G, Bakbak B, Ş G, Okudan S. Short-Term Clinical Results of Preferred Retinal Locus Training. Turk J Ophthalmol. 52(1):14–22. doi:10.4274/tjo.galenos.2021.73368
   PubMedGoogle Scholar
• Sabel BA, Henrich-Noack P, Fedorov A, Gall C. Vision restoration after brain and retina damage: the ”residual vision activation theory”. Prog Brain Res. 2011;192:199–262. doi:10.1016/B978-0-444-53355-5.00013-0
   PubMed Web of Science ®Google Scholar
• Dominguez E, Raoul W, Calippe B, et al. Experimental branch retinal vein occlusion induces upstream pericyte loss and vascular destabilization. PLoS One. 2015;10:e0132644. doi:10.1371/journal.pone.0132644
   PubMed Web of Science ®Google Scholar
• Widihastha SH, Iskandar E, Satari K, Irfani I, Virgana R, Amiruddin PO. Vision rehabilitation using microperimetric biofeedback training in age-related macular degeneration. Int J Ophthalmol. 2023;16(6):933–938. PMID: 37332539; PMCID: PMC10250943. doi:10.18240/ijo.2023.06.16
   PubMed Web of Science ®Google Scholar
• Ferris FL 3rd, Podgor MJ, Davis MD, Group DR. Macular edema in diabetic retinopathy study patients: diabetic retinopathy study report number 12. Ophthalmology. 1987;94(7):754–760. doi:10.1016/S0161-6420(87)33526-2
   PubMed Web of Science ®Google Scholar
• Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116(1):57–65. e5. doi:10.1016/j.ophtha.2008.10.018
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK. Chung CY, et al.MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–1431. doi:10.1056/NEJMoa054481
   PubMed Web of Science ®Google Scholar
• Heier JS, Brown DM, Chong V, et al. VIEW 1 and VIEW 2 Study Groups Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119(12):2537–2548. doi:10.1016/j.ophtha.2012.09.006
   PubMed Web of Science ®Google Scholar
• Csaky KG, Richman EA, Ferris FL. Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium. Invest Ophthalmol Vis Sci. 2008;49(2):479–489. doi:10.1167/iovs.07-1132
   PubMed Web of Science ®Google Scholar
• Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA. Sunness JS, et al.Progression of stargardt disease study group the natural history of the progression of atrophy secondary to stargardt disease (progstar) studies: design and baseline characteristics: progstar report no. 1. Ophthalmology. 2016;123(4):817–828. doi:10.1016/j.ophtha.2015.12.009
   PubMed Web of Science ®Google Scholar
• Nair P, Aiello LP, Gardner TW, Jampol LM, Ferris FL. Report from the NEI/FDA diabetic retinopathy clinical trial design and endpoints workshop. Invest Ophthalmol Vis Sci. 2016;57(13):5127. doi:10.1167/iovs.16-20356
   PubMed Web of Science ®Google Scholar
• Csaky K, Ferris F 3rd, Chew EY, Nair P, Cheetham JK, Duncan JL. Report from the NEI/FDA endpoints workshop on age- related macular degeneration and inherited retinal diseases. Invest Ophthalmol Vis Sci. 2017;58(9):3456–3463. doi:10.1167/iovs.17-22339
   PubMed Web of Science ®Google Scholar
• Thompson DA, Iannaccone A, Ali RR, et al. Monaciano consortium advancing clinical trials for inherited retinal diseases: Recommendations from the second monaciano symposium. Transl Vis Sci Technol. 2020;9(7):2. doi:10.1167/tvst.9.7.2
   PubMed Web of Science ®Google Scholar
• Gonzalez VH, Boyer DS, Schmidt-Erfurth U, et al. Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a Phase 2 study of intravitreal aflibercept. Retina. 2015;35(4):687–694. doi:10.1097/IAE.0000000000000430
   PubMed Web of Science ®Google Scholar
• Samara WA, Shahlaee A, Sridhar J, Khan MA, Ho AC, Hsu J. Quantitative optical coherence tomography angiography features and visual function in eyes with branch retinal vein occlusion. Am J Ophthalmol. 2016;166:76–83. doi:10.1016/j.ajo.2016.03.033
   PubMed Web of Science ®Google Scholar
• Spaide RF, Suzuki M, Yannuzzi LA, Matet A, Behar-Cohen F. Volume-rendered angiographic and structural optical coherence tomography angiography of macular telangiectasia type 2. Retina. 2017;424–435. doi:10.1097/IAE.0000000000001344
   PubMed Web of Science ®Google Scholar
• Minnella AM, Federici M, Pagliei V, et al. Short-term assessment of intravitreal dexamethasone implant using enhanced-depth image optical coherence tomography and optical coherence tomography angiography in patients with retinal vascular diseases. Adv Ther. 2019;36(2):416–425. PMID: 30565180; PMCID: PMC6824342. doi:10.1007/s12325-018-0848-0
   PubMed Web of Science ®Google Scholar
• Noma H, Mimura T, Yasuda K, Shimura M. Role of soluble vascular endothelial growth factor receptor signalling and other factors or cytokines in central retinal vein occlusion with macular edema, 2015. Invest Ophthalmol Vis Sci. 56:1122–1128. doi:10.1167/iovs.14-15789
   PubMed Web of Science ®Google Scholar
• Silvestri V, De Rossi F, Piscopo P, et al. The effect of varied microperimetric biofeedback training in central vision loss: a randomized trial. Optom Vis Sci.;100(11):737–744. PMID: 37747894. doi:10.1097/OPX.0000000000002073
   PubMed Web of Science ®Google Scholar
• Yang Y, Dunbar H. Clinical perspectives and trends: Microperimetry as a trial endpoint in retinal disease. Ophthalmologica. 2021;244(5):418–450. PMID: 33567434; PMCID: PMC8686703. doi:10.1159/000515148
   PubMed Web of Science ®Google Scholar
• Daibert-Nido M, Patino B, Markowitz M, Markowitz SN. Rehabilitation with biofeedback training in age-related macular degeneration for improving distance vision. Can J Ophthalmol. 2019;54(3):328–334. PMID: 31109472. doi:10.1016/j.jcjo.2018.10.016
   PubMed Web of Science ®Google Scholar
• Morales MU, Saker S, Wilde C, Rubinstein M, Limoli P, Amoaku WM. Biofeedback fixation training method for improving eccentric vision in patients with loss of foveal function secondary to different maculopathies. Int Ophthalmol. 2020;40(2):305–312. PMID: 31583549. doi:10.1007/s10792-019-01180-y
   PubMed Web of Science ®Google Scholar
• Lesmes LA, Jackson ML, Bex P. Visual function endpoints to enable dry AMD clinical trials. Drug Discov Today Ther Strateg. 2013;10(1):e43–50. doi:10.1016/j.ddstr.2012.11.002
   PubMedGoogle Scholar
• Wu Z, Jung CJ, Ayton LN, Luu CD, Guymer RH. Test–retest repeatability of microperimetry at the border of deep scotomas. Invest Ophth Visual Sci. 2015;56(4):2606–2611. doi:10.1167/iovs.14-15977
   PubMed Web of Science ®Google Scholar
• Kızıltaş B, Fidancı I. Anxiety and mood in patients undergoing intravitreal injection. Eur Rev Med Pharmacol Sci. 2024 Feb;28(4):1289–1294. doi: 10.26355/eurrev_202402_35450. PMID: 38436162
   PubMedGoogle Scholar